Fact CheckerSign in

NCT05970406Enrolling by invitation

High Intensity Dysphagia Rehab for Acute Ischemic Stroke Patients

Effects of High Intensity Dysphagia Rehabilitation on Adults With Dysphagia s/p Acute Ischemic Stroke in an Acute Rehab Facility

Source: ClinicalTrials.gov · Last updated 12 Nov 2025

Brief summary (registry, in English)

The purpose of this study is to determine a standardized protocol for swallowing therapy and this protocol's effects on recovery after a stroke

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
60 (estimated)
First submitted
24 Jul 2023
Start date
30 Nov 2023
Primary completion date
30 Nov 2026
Lead sponsor
Johns Hopkins University
Diseases
Stroke
NCT number
NCT05970406

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 30 Nov 2023 to the primary completion date, 30 Nov 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Hemorrhagic Stroke, Subarachnoid hemorrhage, subdural hematoma, epidural hematoma
  • Advanced progressive neurological disease

Age

  • Younger than 18, older than 100

Other

  • h/o dysphagia

Who the study is looking for

  • Ages 18-99
  • Ischemic Stroke
  • Identified to have acute dysphagia s/p ischemic stroke
  • Able to follow 1-step commands for swallowing directions

Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Johns Hopkins Bayview Medical Center
Coordinator of this site? Confirm its status
BaltimoreUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.